Evidence map›Paper›PMID 27581825›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2016

What type of clinical evidence is needed to assess medical devices?

Rosanna Tarricone, Paola Roberta Boscolo, Patrizio Armeni

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines).Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  12. Article
  13. Article
  14. Observational study investigating EctoinEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rosanna TarriconeCERGAS, Centre for Research on Social and Healthcare Management, Bocconi University, Milan, Italy Dept of Policy Analysis and Public Management, Bocconi University, Milan, Italy rosanna.tarricone@unibocconi.it.
Paola Roberta BoscoloCERGAS, Centre for Research on Social and Healthcare Management, Bocconi University, Milan, Italy.
Patrizio ArmeniCERGAS, Centre for Research on Social and Healthcare Management, Bocconi University, Milan, Italy.
Bocconi University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this mini-review is to discuss the role of real-world studies as a source of clinical evidence when experimental studies, such as randomised controlled trials (RCTs), are not available. Waiting for RCT evidence when the technology is diffusing could be anti-economical, inefficient from the policy perspective and methodologically questionable.We explain how real-world studies could provide relevant evidence to decision makers. Matching techniques are discussed as a viable solution for bias reduction.We describe a case study concerning a cost-effectiveness analysis based on real-world data of a technology already in use: Mitraclip combined with medical therapy versus medical therapy alone in patients with moderate-to-severe mitral regurgitation. The CEA has encountered the scepticism of most reviewers, due not to the statistical methodology but to the fact that the study was observational and not experimental. Editors and reviewers converged in considering real-world economic evaluations premature in the absence of a RCT, even if in the meantime the technology had been implanted >30 000 times. We believe there is a need to acknowledge the importance of real-world studies, and engage the scientific community in the promotion and use of clinical evidence produced through observational studies.

Indexed as

Device ApprovalEquipment and SuppliesEvidence-Based MedicineCardiac CatheterizationCost-Benefit AnalysisDiffusion of InnovationEquipment DesignEquipment FailureEquipment SafetyHealth Care CostsHumansMedical Device LegislationMitral Valve InsufficiencyPolicy MakingSeverity of Illness IndexTreatment Outcome

Identifiers

PMID27581825
PMCPMC9487219
OpenAlexW2513797370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.